These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10328600)

  • 21. Treatment of testicular tumours based on risk factors.
    Schmoll HJ
    Curr Opin Urol; 1999 Sep; 9(5):431-8. PubMed ID: 10579082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management and survival of patients with advanced germ-cell tumours: improving outcome in intermediate and poor prognosis patients.
    Bhala N; Coleman JM; Radstone CR; Horsman JM; George J; Hancock BW; Hatton MQ; Coleman RE
    Clin Oncol (R Coll Radiol); 2004 Feb; 16(1):40-7. PubMed ID: 14768754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group].
    Nakagawa S; Miki T; Akaza H; Ozono S; Okano T; Sonoda Y; Tsukamoto T; Terachi T; Naito K; Naito S; Nishiyama T; Nonomura N; Hara I; Hoshi S; Yoshida O
    Hinyokika Kiyo; 1999 Nov; 45(11):805-9. PubMed ID: 10637748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council.
    de Wit R; Roberts JT; Wilkinson PM; de Mulder PH; Mead GM; Fosså SD; Cook P; de Prijck L; Stenning S; Collette L
    J Clin Oncol; 2001 Mar; 19(6):1629-40. PubMed ID: 11250991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Refractory germ cell cancer of testis treated by salvage high-dose chemotherapy: report of three cases].
    Tanji S; Obara W; Sugimura J; Ohmori S; Matsushita Y; Tokunaga H; Konda R; Fujioka T; Murai K; Ishida Y
    Hinyokika Kiyo; 2004 Feb; 50(2):77-80. PubMed ID: 15101160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: the French experience.
    Fléchon A; Biron P; Droz JP
    Int J Cancer; 1999 Dec; 83(6):844-7. PubMed ID: 10597208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
    Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
    Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.
    de Wit R; Stoter G; Sleijfer DT; Neijt JP; ten Bokkel Huinink WW; de Prijck L; Collette L; Sylvester R
    Br J Cancer; 1998 Sep; 78(6):828-32. PubMed ID: 9743309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
    Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
    Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metachronous intracranial germinoma in a patient with a previous primary mediastinal seminoma.
    Bedano PM; Bonnin J; Einhorn LH
    J Clin Oncol; 2006 May; 24(15):2386-7. PubMed ID: 16710037
    [No Abstract]   [Full Text] [Related]  

  • 32. [Testicular germ cell tumors].
    Dourthe LM; Ouachet M; Fizazi K; Droz JP
    Bull Cancer; 1998 Sep; (1 Suppl):26-39. PubMed ID: 9817070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant germ cell tumors in childhood.
    Nair R; Pai SK; Saikia TK; Nair CN; Kurkure PA; Gopal R; Sampat MS; Advani SH
    J Surg Oncol; 1994 Jul; 56(3):186-90. PubMed ID: 7518019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
    Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
    Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
    J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian germ cell tumors.
    Cusidó MT; Jordá B; Gonzalez J; García A; Xercavins J
    Eur J Gynaecol Oncol; 1998; 19(2):130-4. PubMed ID: 9611051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extragonadal germ cell tumor: a clinical study.
    Bassetto MA; Pasini F; Franceschi T; Mustacchi G; Cetto GL
    Anticancer Res; 1995; 15(6B):2751-4. PubMed ID: 8669858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
    Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
    Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.